בשל "הגנת זכויות יוצרים" מובא להלן קישור לתקציר המאמר. לקריאתו בטקסט מלא, אנא פנה/י לספרייה הרפואית הזמינה לך.

Several national breast implant registries, designed as Clinical Quality Registries (CQRs), have been founded over the past decade, including Australia, Netherlands, Denmark, Sweden, the United States, the United Kingdom and Italy.

This occurred in response to worldwide breast implant controversies, and is supported by the European New Regulation on Medical devices.

More recently, questions about breast implant safety have been raised in mainstream and social media related to breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL), breast implant illness (BII) and the limitations of pre- and post-market approval studies.

These factors have led to demands from patients, legislators, clinicians and industry for a stricter monitoring of breast implant performance and quality of care.